September 23rd, 2009
Kevan L. Hartshorn, MD received two subcontract grants with Principal Investigator, Barbara Seaton, PhD, of Boston University, entitled “Collectins and Innate Defense against Inhaled Pathogens” and “Structural Basis of Antiviral Activity of Collectins,” both of which have been funded by the NIH.
George Murphy, PhD received a subcontract grant with Principal Investigator, Darrell N. Kotton, MD, of Boston University entitled “Characterization of human hematopoietic and endodermal progenitors derived from iPS and ES cells” funded by the NIH RC2.
Xuemei Zhong, PhD was awarded a Department of Medicine pilot grant application entitled “Effects of Thymic Infiltration of B Cells on Central Immune Tolerance in a Murine Lupus Model” which has been selected for co-funding by the Department of Medicine and the BU Bridge (Boston University Clinical and Translational Science Institute).
August 24th, 2009
Omar Eton, M.D. has been appointed attending medical oncologist at Boston Medical Center (BMC) and Associate Professor of Medicine at Boston University School of Medicine (BUSM). Dr. Eton attended New York University School of Medicine and completed an internal medicine residency at Parkland Memorial Hospital at the University of Texas Southwestern in Dallas, Texas. He then served as an American Cancer Society fellow at Memorial Sloan-Kettering Cancer Center training in oncology, hematology, and tumor immunology. He joined the medical oncology staff of MD Anderson Cancer Center in Houston, Texas in the Melanoma Section and became the principal investigator for numerous clinical trials of vaccines, cytokines, intra-arterial therapy, and small molecule therapeutics for melanoma. He refined the staging of advanced melanoma and was a leader in the development of combined biochemotherapy, the most active regimen for patients with metastatic melanoma. He pioneered the clinical development of an autologous tumor-derived heat-shock protein peptide vaccine and of imatinib(Gleevec) as a targeted therapeutic.
Called up as an Air Force reservist after 9/11, Dr. Eton participated in humanitarian medical missions in South America and in Africa. Afterwards, he joined the oncology drug development team at Millennium Pharmaceuticals and led the international program developing and testing a novel aurora A kinase inhibitor.
At Boston Medical Center, Dr. Eton will serve as a solid tumor oncologist with a special interest in melanoma, targeted therapies, and clinical trials. Dr. Eton has been a fellow of the American College of Physicians and a member of the American Society of Clinical Oncology and the American Society of Hematology.
Duyen Ngo, M.D. has been appointed attending physician in the Section of Hematology and Oncology at Boston Medical Center and Instructor at Boston University School of Medicine. Dr. Ngo received her medical degree from the University of Minnesota Medical School. She completed her internal medicine residency at Massachusetts General Hospital and fellowship in hematology and oncology at Boston Medical Center. Her research as a Sickle Cell Scholar will focus on understanding genetic determinants of hemoglobin F levels and other modifiers of clinical phenotype in patients with sickle cell disease. Her clinical interests include anemias, iron disorders, coagulopathies, sickle cell disease and other hemoglobinopathies, platelet disorders, immune-mediated cytopenias, and other hematologic disorders.
April 16th, 2009
BASEBALL TOURNEY
“STRIKE OUT COLON CANCER”
APRIL 18TH AND 19TH, 2009
SARTORI (EAST BOSTON) STADIUM
| 12:00 PM |
NEWTON SOUTH HIGH HIGH SCHOOL
VS
MALDEN HIGH SCHOOL |
CONSOLATION GAME |
| 3:00 PM |
EAST BOSTON HIGH SCHOOL
VS
REVERE HIGH SCHOOL |
CHAMPIONSHIP GAME |
Come suppor this great effort!
–Sponsed by First Priority Credit Union
East Boston loves the Red Sox
But, high school baseball really rocks!!!
**Call Bob at 617.638.7540 for more information and directions**
April 9th, 2009
Dr. J. Mark Sloan presented a talk at MGH entitled, “A is for Amyloid.”
Dr. Carol Rosenberg discussed breast cancer research findings in a Boston Channel 5 News story entitled, “African American women are at the highest risk for aggressive tumors.” Click here to view the Channel 5 video. To read the featured news item, please click here. To read more about Dr. Rosenberg’s research, view the publication.
Boston University’s Science and Engineering Day was open to all science, engineering and math graduate students and post docs. Beth M. Hovey, PhD candidate from Dr. Seldin’s lab, was judged on her poster entitled, “siRNA, a Potential Therapy for AL Amyloidosis”and given the highest honor, “The President’s Award”. To view more information please visit Boston University’s Research website.
February 25th, 2009
Drs. Sanchorawala and Sloan are co-authors in a new book “Myeloma Therapy”, edited by Lonial. Chapter 28: Anemia and Erythropoietic Growth Factors in Multiple Myeloma (Sloan) and Chapter 33: AL Amyloidosis (Sanchorawala).
“Reaccreditation with Commendation of the Cancer Programs by the American College of Surgeons.” For more information, please visit www.acosog.org
Dr. Vaishali Sanchorawala presented a talk at the International Myeloma Working Group Meeting in Washington on, “Improving Care for Patients with Amyloidosis” in the session on, “Future Directions and Strategies in the Evaluation and Treatment of Clonal Plasma Cell Disorders”.
At the annual ASBMT meeting, Kathy Finn, NP presented on, “Clinical Pathways and Standard Operating Procedures: Essential Tools for Outpatient Stem Cell Transplant Programs Treating Patients with AL Amyloidosis.” Michael Rosenzweig, MD presented a poster on ”Febrile Reactions Occurring with Second Cycle of High Dose Melphalan and Stem Cell Transplantation in Patients with AL Amyloidosis: A “Melphalan Recall” Reaction”. Dr. Vaishali Sanchorawala delivered and oral presentation on, “Treatment-Related Mortality In Patients With AL Amyloidosis Undergoing High-Dose Melphalan And Stem Cell Transplantation: Trend Over The Past 14 Years At A Single Institution.”
December 12th, 2008
Dr. Carol Rosenberg will join the editorial board of the, Journal of Clinical Oncology in January of 2009.
December 9th, 2008
Beth M. Hovey, PhD Candidate in Dr. David Seldin’s lab presented a poster on “siRNA, A Potential Therapy for AL Amyloidosis.”
Dr. Vaishali Sanchorawala presented a talk titled, ”Treatment-Related Mortality in Patients with AL Amyloidosis Undergoing High-Dose Melphalan and Stem cell Transplantation: Trend over the Past 14 year at a Single Institution.”
The Name of the session was, “Clinical Transplantation – transplantation regimen toxicities and engraftment.”
Dr. Michael Rosenzweig presented, “Febrile Reactions Occurring with Second Cycle of High Dose Melphalan and Stem Cell Transplantation in Patients with AL Amyloidosis: A “Melphalan Recall” Reaction.”
Dr. Zhao Lu presented a poster titled, “A Head-to-Head Comparison Between Cyclophosphamide and Ontak in Reducing the Influence of Tregs on Self (Tumor) Peptide-Specific CTL Responses.”
Click here for more information about the American Society of Hematology.
November 17th, 2008
Dr. Adam Lerner presents on the topic, “Chronic Lymphocytic Leukemia,” at the Medical Grand Rounds, West Roxbury VA Hospital.
October 16th, 2008
Dr. Isabel Dominguez will receive departmental support through the Department of Medicine Faculty Development Program to attend the course, “Leadership training program for scientists” offered by the Massachusetts Biotechnology Education Foundation.
For more information on this program, please visit: https://secure.massbioed.org/courses/index.php?page_function=detail&course_id=10
